NNC0363-1063

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC0363-1063, covering 2026-01-02 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes [Phase 1]

See pricing